As of 2026-03-15, the Fair Value of Sutro Biopharma Inc (STRO) is -83.42 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 23.08 USD, the upside of Sutro Biopharma Inc is -461.43%.
With the market price of 23.08 USD and our fair value calculation, Sutro Biopharma Inc (STRO) is not a good investment. Investing in STRO stocks now will result in a potential loss of 461.43%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -32.13 | -105.54 | -119.20 | -106.79 | -227.46 | -118.22 |
| YoY growth | 42.36% | -228.48% | -12.94% | 10.41% | -112.99% | -60.33% |
| Market Cap (mil) | 299.26 |
| P/E | |
| Forward P/E |
| EPS | -16.68 |
| Avg earnings growth rate | -60.33% |
| TTM earnings | -216.32 |